Related Articles
Response‑specific progestin resistance in a newly characterized Ishikawa human endometrial cancer subcell line resulting from long‑term exposure to medroxyprogesterone acetate
Use of a murine endometriosis interna model for the characterization of compounds that effectively treat human endometriosis
The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development
Luteolin suppresses development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats
The advance of the third‑generation EGFR‑TKI in the treatment of non‑small cell lung cancer (Review)